Posted inHealthy News
Lucid-21-302 MS clinical trial doses 1st group of healthy volunteers | FSD Pharma testing safety, tolerability of therapy dubbed Lucid-MS
FSD Pharma has completed dosing in the first group of healthy volunteers enrolled in its Phase 1 clinical trial testing Lucid-21-302, an oral medication candidate for all types of multiple…
